Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

investorenquiries@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

December 1, Demonstration Batch Small MPL Tablets Completed

211201_DemonstrationTabletsComplete

Categories: Financial Reports 2017, News and Announcements 2021By PharmAust December 1, 2021

Related posts

December 15, Epichem Awarded DNDi Extension
December 15, 2021

December 13, Shareholder Update and Strategy
December 13, 2021

December 1, Top 20 Shareholders
December 1, 2021

November 17, FightMND and COVID-19 Trials on Track
November 17, 2021

November 15, New Zealand Joins Phase 2B Pet Dog Trial
November 15, 2021

November 1, Top 20 Shareholders
November 1, 2021

Recent Articles

Notice of General Meeting
May 26, 2023
Motor Neurone Disease Clinical Trial Update
May 22, 2023
Progress update on Phase 1/2 MND interim analysis
May 16, 2023
Independent tests show MPL retains long-term shelf-life
May 10, 2023

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

pharmaust Follow

@ ·

now

Reply on Twitter Retweet on Twitter Like on Twitter Twitter

Load More

Copyright © 2023 PharmAust. All rights reserved.

nil

Website Design & Digital Marketing Perth by Total Click Solutions